Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China flag China · Delayed Price · Currency is CNY
28.08
-0.75 (-2.60%)
At close: Apr 9, 2026

SHE:301089 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-69.66-19.88243.07286.5465.71
Depreciation & Amortization
66.2747.6646.5940.5230.92
Other Amortization
0.880.880.520.470.57
Loss (Gain) From Sale of Assets
-0.01--0.03-
Asset Writedown & Restructuring Costs
16.391.424.221.031.34
Loss (Gain) From Sale of Investments
-4.12-1.55-7.12-5.77-0.63
Provision & Write-off of Bad Debts
-4.084.48-5.112.28
Other Operating Activities
12.629.9211.1112.489.5
Change in Accounts Receivable
-15.0772.83-57.67-100.76-27.49
Change in Inventory
-15.3514.5537.75-72.92-21.38
Change in Accounts Payable
-14.45-19.28-264.08172.6-61.71
Change in Unearned Revenue
----16.83
Change in Other Net Operating Assets
----40.99
Operating Cash Flow
-26.19102.6726.95268.8558.19
Operating Cash Flow Growth
-280.91%-89.98%361.99%-51.51%
Capital Expenditures
-44.45-83.91-185.22-148.33-112.73
Sale of Property, Plant & Equipment
-0.60.040.0810
Investment in Securities
114.82-6056.57-20.4-220
Other Investing Activities
0.173.43-6.24-
Investing Cash Flow
70.54-139.88-128.61-162.41-322.73
Short-Term Debt Issued
---90131.4
Total Debt Issued
---90131.4
Short-Term Debt Repaid
-----193.82
Long-Term Debt Repaid
--0.94-40-115.42-44.93
Total Debt Repaid
--0.94-40-115.42-238.75
Net Debt Issued (Repaid)
--0.94-40-25.42-107.35
Issuance of Common Stock
--21.6-558.81
Common Dividends Paid
--31.64-50.67-14.98-7.92
Dividends Paid
--31.64-50.67-14.98-7.92
Other Financing Activities
-1.21----11.3
Financing Cash Flow
-1.21-32.57-69.07-40.4432.23
Foreign Exchange Rate Adjustments
-0.290.830.110.97-0.73
Net Cash Flow
42.86-68.95-170.6267.01166.97
Free Cash Flow
-70.6418.76-158.27120.52-54.53
Free Cash Flow Margin
-18.67%4.45%-18.94%15.36%-10.85%
Free Cash Flow Per Share
-0.560.15-1.260.95-0.55
Cash Income Tax Paid
17.3-7.9823756.0920.74
Levered Free Cash Flow
-9.1234.73-156.56106.83-139.19
Unlevered Free Cash Flow
-9.1234.76-156.35108.94-133.48
Change in Working Capital
-48.5660.14-275.92-61.28-51.49
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.